Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Albert Labs has announced Sara Tai, Senior Lecturer in Clinical Psychology from Manchester University, as Principal Investigator for its upcoming trial. The trial will evaluate the safety and efficacy of KRN-101, a psilocybin-based medicine, for the treatment of cancer-related distress.

Category Press Release
Published in Yahoo Finance

Companies Featured

Albert Labs
Albert Labs is a publicly listed company (CSE) that uses Real-World Evidence (RWE) to accelerate the psychedelic drug development process.